Clover Health Investments Stock News

Investors need to pay close attention to Clover Health (CLOV) stock based on the movements in the options market lately.

Clover Health Investments (NASDAQ:CLOV) had its price target upped by research analysts at Credit Suisse Group from $8.00 to $9.00 in a research report issued to clients and investors on Monday, Analyst Price Targets reports. The brokerage presently has a neutral rating on the stock. Credit Suisse Groups price objective suggests a potential upside of []

Shares of Clover Health Investments, Corp. (NASDAQ:CLOV) were up 5.3% during trading on Monday after Credit Suisse Group raised their price target on the stock from $8.00 to $9.00. Credit Suisse Group currently has a neutral rating on the stock. Clover Health Investments traded as high as $7.67 and last traded at $7.54. Approximately 413,173 []

NEW YORK, Nov. 16, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SNDL, NAKD, CLOV, QS, and CRON. Full story available on Benzinga.com

The stock price of Clover Health Investments Corp (NASDAQ: CLOV) fell by over 9% during intraday trading today. This is why it happened.

Clover Health Investments (CLOV) has initiated an underwritten public offering of 35 million shares of its Class A common stock. Following the news, shares of The post Clover Health Commences Class A Common Stock Offering; Shares Drop appeared first on Smarter Analyst .

Clover Health Investments Corp (NASDAQ: CLOV) shares are trading lower after the company reported a 35 million share common stock offering during Monday's after-hours session. All of the shares are be

The Medicare tech company just gave some disappointing news.

Clover Health Investments, Corp. (NASDAQ:CLOV) shares traded up 5.3% on Monday after Credit Suisse Group raised their price target on the stock from $8.00 to $9.00. Credit Suisse Group currently has a neutral rating on the stock. Clover Health Investments traded as high as $7.67 and last traded at $7.54. 413,173 shares were traded during []

A combination of triple-digit growth, expanding provider networks and a low share price make CLOV stock hard to resist. The post Revenue Growth Makes Clover Health Stock a Strong Buy appeared first on

NASHVILLE, Tenn., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV), (Clover Health), a technology company committed to improving health equity for seniors, today announced that it has commenced an underwritten public offering of 35,000,000 shares of its Class A Common Stock. All of the shares are being offered by Clover Health. In conjunction with the offering,

Providing an update on its metrics, next-generation healthcare company Clover Health (CLOV) has announced that it expects total Lives under Clover Management to rise The post Clover Health Provides Update on Metrics appeared first on Smarter Analyst .

These health care industry players continue to serve the masses amid the current pandemic.

Clover Health Investments, Corp. (CLOV) CEO Vivek Garipalli on Q3 2021 Results - Earnings Call Transcript

Clover Health's poor insurance underwriting performance dragged down CLOV stock. However, the company may be making progress.